XAGRID 0.5 mg, hard capsule 100 capsules, parallel import (Abacus Medicine A/S)
Active ingredients: Anagrelide, Anagrelide hydrochloride monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule100 capsules, parallel import (Abacus Medicine A/S)orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XAGRID 0,5 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité de 100 gélule(s) (Distributeur Parallèle : Abacus Medicine A/S)
- Marketing authorisation holder
- TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 May 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64599534CIP74950169CIP133400949501694Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ANAGRÉLIDE (CHLORHYDRATE D') MONOHYDRATÉgélule | 0,61 mg · une gélule | SA |
| ANAGRÉLIDEgélule | 0,5 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.